These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Overview of the cellular and molecular basis of kidney fibrosis. Eddy AA Kidney Int Suppl (2011); 2014 Nov; 4(1):2-8. PubMed ID: 25401038 [TBL] [Abstract][Full Text] [Related]
23. Noninvasive Assessment of Fibrosis Following Ischemia/Reperfusion Injury in Rodents Utilizing Na Magnetic Resonance Imaging. Nielsen PM; Mariager CØ; Rasmussen DGK; Mølmer M; Genovese F; Karsdal MA; Laustsen C; Nørregaard R Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32824113 [TBL] [Abstract][Full Text] [Related]
25. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease]. Nakagawa S Yakugaku Zasshi; 2017; 137(11):1355-1360. PubMed ID: 29093371 [TBL] [Abstract][Full Text] [Related]
26. Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease. Owens EP; Vesey DA; Kassianos AJ; Healy H; Hoy WE; Gobe GC Transl Androl Urol; 2019 May; 8(Suppl 2):S175-S183. PubMed ID: 31236335 [TBL] [Abstract][Full Text] [Related]
27. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504 [TBL] [Abstract][Full Text] [Related]
29. Renal fibrosis: insight from proteomics in animal models and human disease. Klein J; Kavvadas P; Prakoura N; Karagianni F; Schanstra JP; Bascands JL; Charonis A Proteomics; 2011 Feb; 11(4):805-15. PubMed ID: 21229585 [TBL] [Abstract][Full Text] [Related]
30. The role of extracellular matrix quality in pulmonary fibrosis. Kristensen JH; Karsdal MA; Genovese F; Johnson S; Svensson B; Jacobsen S; Hägglund P; Leeming DJ Respiration; 2014; 88(6):487-99. PubMed ID: 25359084 [TBL] [Abstract][Full Text] [Related]
31. Bcl-3 is a novel biomarker of renal fibrosis in chronic kidney disease. Chen R; Wang L; Liu S; Chen X; Hu Y; Liu H; Zhang H; Jiang Y; Wang Q; Ye D; Li L; Liu D; Pan X; Wei L; Li X; Zhang X Oncotarget; 2017 Nov; 8(57):97206-97216. PubMed ID: 29228604 [TBL] [Abstract][Full Text] [Related]
32. Urinary Biomarkers of Renal Fibrosis. Zhou LT; Lv LL; Liu BC Adv Exp Med Biol; 2019; 1165():607-623. PubMed ID: 31399987 [TBL] [Abstract][Full Text] [Related]
33. MicroRNAs in renal fibrosis. Chung AC; Lan HY Front Physiol; 2015; 6():50. PubMed ID: 25750628 [TBL] [Abstract][Full Text] [Related]
34. Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review. Mansour SG; Puthumana J; Coca SG; Gentry M; Parikh CR BMC Nephrol; 2017 Feb; 18(1):72. PubMed ID: 28219345 [TBL] [Abstract][Full Text] [Related]
35. RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice. Zhou Z; Ni J; Li J; Huo C; Miao N; Yin F; Cheng Q; Xu D; Xie H; Chen P; Zheng P; Zhang Y; Zhou L; Zhang W; Yu C; Liu J; Lu L J Mol Med (Berl); 2020 Apr; 98(4):527-540. PubMed ID: 32036390 [TBL] [Abstract][Full Text] [Related]
37. Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats. Schierwagen R; Leeming DJ; Klein S; Granzow M; Nielsen MJ; Sauerbruch T; Krag A; Karsdal MA; Trebicka J Front Physiol; 2013; 4():195. PubMed ID: 23908632 [TBL] [Abstract][Full Text] [Related]
38. Current Opinion for Hypertension in Renal Fibrosis. Sun HJ Adv Exp Med Biol; 2019; 1165():37-47. PubMed ID: 31399960 [TBL] [Abstract][Full Text] [Related]
39. Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial fibrosis of chronic progressive nephropathy in aged rats. Nakatsuji S; Yamate J; Sakuma S Vet Pathol; 1998 Sep; 35(5):352-60. PubMed ID: 9754540 [TBL] [Abstract][Full Text] [Related]